Aims The aim of the present paper was to provide an up‐to‐date view on epidemiology and
risk factors of heart failure (HF) development after myocardial infarction. Methods and results …

Abstract Sodium glucose cotransporter-2 (SGLT2) inhibitors improve cardiorenal outcomes
in patients with type 2 diabetes mellitus, chronic kidney disease, and chronic heart failure …

Background: Rates for recurrent coronary heart disease (CHD) events have declined in the
United States. However, few studies have assessed whether this decline has been similar …

Despite mounting evidence of the positive relationship between diabetes mellitus (DM) and
heart failure (HF), the entire context of the magnitude of risk for HF in relation to DM remains …

Aim Mortality from acute myocardial infarction (AMI) has declined, increasing the pool of
survivors at risk of later development of heart failure (HF). However, coronary reperfusion …

Background The outcome of patients with acute myocardial infarction (AMI) may vary
substantially based on baseline risk. We aimed at analyzing the impact of gender, age and …

Aims Myocardial infarction (MI) is among the commonest attributable risk factors for heart
failure (HF). We compared clinical characteristics associated with the progression to HF in …

Introduction and objectives Coronary heart disease is the leading cause of heart failure (HF).
The aim of this study was to assess the risk of readmission for HF in patients with acute …

Background Previous studies investigating predictors of Heart Failure (HF) after acute
coronary syndrome (ACS) were mostly conducted during fibrinolytic era or restricted to …

Left ventricular remodeling (LVR) after ST-elevation myocardial infarction (STEMI) is
generally thought to be an adaptive but compromising phenomenon particularly in patients …